8HH Stock | | | EUR 17.60 0.20 1.15% |
VP
William Haydon is VP Management of Avanos Medical
Age | 56 |
Phone | 844 428 2667 |
Web | https://avanos.com |
Avanos Medical Management Efficiency
The company has return on total asset
(ROA) of
0.0236 % which means that it generated a profit of $0.0236 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity
(ROE) of
0.0348 %, meaning that it generated $0.0348 on every $100 dollars invested by stockholders. Avanos Medical's management efficiency ratios could be used to measure how well Avanos Medical manages its routine affairs as well as how well it operates its assets and liabilities.
Avanos Medical has accumulated 130
M in total debt with debt to equity ratio
(D/E) of 25.6, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Avanos Medical has a current ratio of 3.0, suggesting that it is
liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Avanos Medical until it has trouble settling it off, either with new capital or with free cash flow. So, Avanos Medical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Avanos Medical sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Avanos to invest in growth at high rates of return. When we think about Avanos Medical's use of debt, we should always consider it together with cash and equity.
Avanos Medical, Inc. operates as a medical technology company that focuses on delivering medical device solutions to improve patients quality of life worldwide. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia. AVANOS MEDICAL operates under Medical Instruments Supplies classification in Germany and is traded on Frankfurt Stock Exchange. It employs 4700 people. Avanos Medical (8HH) is traded on Frankfurt Exchange in Germany and employs 4,555 people.
Management Performance
Avanos Medical Leadership Team
Elected by the shareholders, the Avanos Medical's board of directors comprises two types of representatives: Avanos Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Avanos. The board's role is to monitor Avanos Medical's management team and ensure that shareholders' interests are well served. Avanos Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Avanos Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Michelle Scharfenberg, VP Officer | |
| Michael Greiner, CFO VP | |
| Scott Galovan, VP Devel | |
| David Crawford, VP Treasurer | |
| Arjun Sarker, Senior Vice President - International | |
| David Ball, Senior Vice President - Global Supply Chain & Procurement | |
| William Haydon, VP Management | |
| Kerr Holbrook, VP Care | |
| Joseph Woody, CEO, Director | |
| Mojirade James, Gen VP | |
Avanos Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Avanos Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Avanos Stock
When determining whether Avanos Medical is a strong investment it is important to analyze Avanos Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Avanos Medical's
future performance.
For an informed investment choice regarding Avanos Stock, refer to the following important reports: Check out
Trending Equities to better understand how to build diversified portfolios, which includes a position in Avanos Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in board of governors.
For more detail on how to invest in Avanos Stock please use our
How to Invest in Avanos Medical guide.
You can also try the
Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Please note, there is a significant difference between Avanos Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Avanos Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Avanos Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.